2017
DOI: 10.1186/s12887-017-0930-9
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent c.G1636A (p.G546S) mutation of COL2A1 in a Chinese family with skeletal dysplasia and different metaphyseal changes: a case report

Abstract: BackgroundMutations in the COL2A1 gene cause type II collagenopathies characterized by skeletal dysplasia with a wide spectrum of phenotypic severity. Most COL2A1 mutations located in the triple-helical region, and the glycine to bulky amino acid substitutions (e.g., glycine to serine) in the Gly-X-Y repeat were identified frequently. However, the same COL2A1 mutations are associated with different phenotypes and the genotype-phenotype relationship is still poorly understood. Therefore, the studies of more pat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 21 publications
1
4
0
Order By: Relevance
“…In addition, there was a polymorphism of clinical manifestations in two probands with a similar variant, where a substitution of glycine to serine at the 546 nucleotide position was detected. One of the patients had typical signs of SEMD and another one had a mild phenotype of SED with normal growth, as confirmed by the data of Chen J. et al [ 27 ], where an interfamily clinical polymorphism was identified in patients with this pathogenic variant. In two patients with newly identified substitutions leading to glycine substitution: c.1348G>C (p.Gly450Arg) and c.3554G>A (p.Gly1185Glu), radiography revealed the presence of enchondroma-like changes in metaphyses, anisospondylia, limb length discrepancy, and abnormal ossification pattern of the pubic bones which are typical for dyspondyloenchondromatosis ( Figure 4 ).…”
Section: Resultssupporting
confidence: 72%
See 1 more Smart Citation
“…In addition, there was a polymorphism of clinical manifestations in two probands with a similar variant, where a substitution of glycine to serine at the 546 nucleotide position was detected. One of the patients had typical signs of SEMD and another one had a mild phenotype of SED with normal growth, as confirmed by the data of Chen J. et al [ 27 ], where an interfamily clinical polymorphism was identified in patients with this pathogenic variant. In two patients with newly identified substitutions leading to glycine substitution: c.1348G>C (p.Gly450Arg) and c.3554G>A (p.Gly1185Glu), radiography revealed the presence of enchondroma-like changes in metaphyses, anisospondylia, limb length discrepancy, and abnormal ossification pattern of the pubic bones which are typical for dyspondyloenchondromatosis ( Figure 4 ).…”
Section: Resultssupporting
confidence: 72%
“…To date, no clear genotype–phenotype correlations have been obtained in type II collagenopathies, which is most likely associated with the existence of the inter- and intrafamilial variability of clinical manifestations, differences in the specificity of clinical manifestations in patients with the same pathogenic variants, age-related evolution of phenotypes, and evidence of marked genetic heterogeneity due to some cases with an autosomal recessive type of inheritance [ 13 , 15 , 23 , 24 , 25 , 26 ]. Nevertheless, conducting a clinical and genetic analysis of various nosological variants of the skeletal collagenopathies spectrum can improve our understanding of the pathogenetic mechanisms and more accurately predict their course at the early stages, improving an individual’s medical care and quality of life [ 27 ].…”
Section: Introductionmentioning
confidence: 99%
“…[31][32][33] It has been postulated that mutations in the triplehelical domain of procollagen a chains can delay the folding of the protein into the triple-helical conformation, thus leading to posttranslational over modification of the protein. [34,24,35] In this study, all affected individuals were found to carry p.Gly1170Ser mutation in exon 50 of COL2A1 gene, which resulted in a change from glycine to serine at codon 1170 (Gly1170Ser). A Gly1170Ser mutation potentially interrupts the mandatory Gly-X-Y triplet sequence required for the normal formation of stable triple-helical type II collagen molecules, which could further lead to the degradation of premature collagen molecules, or to the production of overmodified type II collagen.…”
Section: Discussionmentioning
confidence: 78%
“…The exception is glycine to serine substitutions. Glycine to serine substitutions, unlike glycine to nonserine residue substitutions, produced variable phenotypes, with both inter- and intra-familial phenotypic variation [ 21 , 22 ]. In type I collagenopathies, the severity of the disease has been correlated with the size and charge of the substituted amino acid, specifically Ala < Ser < Cys < Arg < Glu < Asp < Val, in order from least to most disruptive [ 23 ].…”
Section: Discussionmentioning
confidence: 99%